Survivorship care

• Monitoring for late toxicity (cardiac, pulmonary, neurologic, endocrine).

• Screening for secondary malignancies (e.g., mammography in women treated with chest RT as teens).

Modern guidelines

• QUANTEC and newer normal tissue dose constraints help minimize risk.

• Survivorship clinics integrate oncology, cardiology, pulmonology, endocrinology.

Patient education

• Long-term risk communication is essential.

• Healthy lifestyle interventions may reduce late toxicity risk.